HROW
HARROW, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$29.18
+2.23%Forward multiples
Based on analyst estimates
- P/E forward
- 17.52x
- P/E 2026E
- —
- P/E 2027E
- 13.05x
- P/E 2028E
- 7.22x
- P/S forward
- 2.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 71.96x
- Price / sales
- 3.97x
- Price / cash flow
- 174.95x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 4.75x
- EV / EBITDA
- 117.12x
- EV / EBIT
- 229.83x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026